• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·India·Technology·LTIM.NS
Share

LTIMindtree Limited Stocks

₹ 4202.7Last Updated 04.05.2026

Issuer Rating

6/7
Performance

Favourable

Risk

Low

Recommendation

Buy

Market Cap

₹ 14.23B

₹ 4202.7
Key Takeaways

Risk factor

Strong & resilient to price shocks

Data is available to registered users only
Data is available to registered users only

Profitability factor

Very strong margins and returns

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

LTIMindtree Limited, a technology consulting and digital solutions company, provides information technology services and solutions in India, North America, Europe, the Asia Pacific, and internationally. The company operates through Banking, Financial Services & Insurance; Manufacturing; Energy & Utilities; High-Tech, Media & Entertainment; and CPG, Retail, Pharma & Others segments. It offers application development, maintenance and outsourcing, enterprise, infrastructure management, testing, digital, and platform-based solutions. LTIMindtree Limited has a strategic collaboration agreement with Amazon Web Services, Inc.; and a strategic partnership with eClinicalHealth Limited to enhance digital innovation in clinical trials management process for patient centric drug development. The company was formerly known as Larsen & Toubro Infotech Limited and changed its name to LTIMindtree Limited in November 2022. The company was incorporated in 1996 and is based in Mumbai, India. LTIMindtree Limited operates as a subsidiary of Larsen & Toubro Limited.

Company Valuation

Slightly overvalued
3/7

Based on key historical and expected multiples, the stock is slightly overvalued relative to its peers. In particular, the stock is reasonably priced on P/E, of fair valu

Data is available to registered users only
Sign up to access detailed valuation

Target Price

Somewhat favourable
5/7

The average target price of LTIM.NS is 5237 and suggests 15% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to inc

Data is available to registered users only
Sign up to access analyst forecasts

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

04.06.2026 08:00

Broadcom let down by software revenue and AI chip outlook. Shares tumble after record high

04.06.2026 07:00

Morgan Stanley called the debut of a new Fed chief a major risk to currency markets

04.06.2026 01:56

Elon Musk's SpaceX has announced its IPO share price. It wants to raise a record $75 billion

04.06.2026 01:50

Strait of Hormuz to open in June, JPMorgan says: oil stocks running out

04.06.2026 01:18

S&P falls for the first time after nine sessions of growth: investors are worried about inflation risks

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn
  • X (Twitter)
  • LinkedIn
Oninvest© 2026